Get complete Patent Opposition Report for Fujian Cosunter Pharmaceutical

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Fujian Cosunter Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3533787Sep 30, 2020Pyridone Compound As C-Met Inhibitor1